EVERSANA Completes Acquisition of Intouch Group, Adds the Premiere Digital-First Agency Network to the Market Leader in Next Generation Commercialization
EVERSANA, the pioneer of next generation commercial services to the global life sciences industry, announced it has completed its acquisition of Intouch Group, a full-service global agency network serving the pharmaceutical industry. The acquisition immediately propels EVERSANA’s position as a $1 billion commercial services leader with more than 40 locations and 5,500 employees worldwide, poised to solve any global pricing, access, reimbursement, promotion, adherence, or product delivery challenge.
“Today marks a milestone day for not only our employees and clients, but for an industry desperately in need of a better way to bring innovations to market, create long-term value, and improve patient lives,” said Jim Lang, CEO of EVERSANA. “With the added power of Intouch and millions more invested in data, analytics and digital transformation, we are reinventing commercial approaches for the benefit of our clients and their patients.”
Recommended AI News: Economically Smart Play-to-Earn Model From Market Hero
Under terms of the agreement announced in October 2021, Intouch’s industry-leading creative and media services, enterprise solutions and data analytics will join EVERSANA’s fully integrated commercialization services platform. Agencies from both firms will integrate, as EVERSANA ENGAGE joins forces with the Intouch agency network. Faruk Capan, CEO of Intouch Group, now reports to Jim Lang.
“This is so much more than an integration. This is our opportunity to improve every sector of product commercialization,” said Capan. “Over the last 20 years we transformed pharmaceutical promotion and digital engagement. Imagine what the next 20 years will bring as we set our sights even higher, unafraid to transform health care as we know it.”
Recommended AI News: Leading Online Marketplace Artnet Launches NFTs Using Monegraph
[To share your insights with us, please write to firstname.lastname@example.org]
Comments are closed.